David Schmidt - 02 Sep 2025 Form 4 Insider Report for Astrana Health, Inc. (ASTH)

Role
Director
Signature
/s/ Kathy Diep, as Attorney-in-Fact
Issuer symbol
ASTH
Transactions as of
02 Sep 2025
Net transactions value
-$191,200
Form type
4
Filing time
03 Sep 2025, 16:15:13 UTC
Previous filing
13 Jun 2025
Next filing
15 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Schmidt David Director C/O ASTRANA HEALTH, INC., 1668 S. GARFIELD AVE, 2ND FLOOR, ALHAMBRA /s/ Kathy Diep, as Attorney-in-Fact 03 Sep 2025 0001594029

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASTH Common Stock Options Exercise $364,000 +20,000 +127% $18.20 35,763 02 Sep 2025 Direct
transaction ASTH Common Stock Disposed to Issuer $555,200 -20,000 -56% $27.76 15,763 02 Sep 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ASTH Stock Option (right to Buy) Options Exercise $0 -20,000 -100% $0.000000 0 02 Sep 2025 Common Stock 20,000 $18.20 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were repurchased by the Issuer.
F2 Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders.
F3 These stock options were fully vested and exercisable.